Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hydrogel biomaterials to support and guide vascularization.

Progress in biomedical engineering (Bristol, England)·2025

Same author

Considerations to Better Meet the Needs of People Living With Diabetes While in Prison or Detention.

Diabetes spectrum : a publication of the American Diabetes Association·2024

Same author

A Pragmatic Rethinking of Glucose Monitoring for the Incarcerated.

Diabetes spectrum : a publication of the American Diabetes Association·2024

Same author

Detection of fluorescent protein mechanical switching in cellulo.

Cell reports methods·2024

Same author

Neurogenic Cell Behavior in 3D Culture Enhanced Within a Highly Compliant Synthetic Hydrogel Platform Formed via Competitive Crosslinking.

Cellular and molecular bioengineering·2024

Same author

Antibiotic exposure is associated with decreased risk of psychiatric disorders.

Frontiers in pharmacology·2024

Search research articles

Related Experiment Video

Updated: Jun 30, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Thermo-responsive systems for controlled drug delivery.

Malavosklish Bikram¹, Jennifer L West

¹University of Houston, College of Pharmacy, Department of Pharmacological and Pharmaceutical Sciences, 1441 Moursund Street, Houston, TX 77030, USA. mbikram@uh.edu

Expert Opinion on Drug Delivery

|September 27, 2008

Summary

This summary is machine-generated.

Temperature-sensitive drug delivery systems offer tunable, targeted drug release for improved treatment. Combining temperature with other stimuli like pH and light enhances control and efficacy in advanced biomedical research.

More Related Videos

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Related Experiment Videos

Last Updated: Jun 30, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Area of Science:

Biomedical Engineering
Materials Science
Pharmacology

Background:

Controlled drug delivery systems are crucial for treating diseases where sustained release is not ideal.
Stimuli-sensitive systems offer precise modulation of drug release.
Temperature-sensitive systems are particularly promising due to design flexibility and tunable properties.

Purpose of the Study:

To explore the potential of temperature-sensitive drug delivery systems.
To investigate methods for enhancing control over drug release mechanisms.
To highlight advances in combining temperature sensitivity with other stimuli for sophisticated drug delivery.

Main Methods:

Development of thermosensitive materials for drug encapsulation.
Characterization of phase transition temperatures and drug release profiles.
Integration of temperature-responsive elements with other stimuli-responsive mechanisms (e.g., pH, light).

Main Results:

Thermosensitive drug delivery systems demonstrate versatility, tunability, and passive targeting capabilities.
These systems effectively overcome limitations of conventional drug delivery, improving efficacy and reducing toxicity.
Multistimuli-responsive systems exhibit exquisite control over drug release kinetics.

Conclusions:

Temperature-sensitive drug delivery systems represent a significant advancement in therapeutic strategies.
The combination of temperature with other stimuli leads to highly sophisticated and controllable drug release.
These innovations hold immense potential for future biomedical research and clinical applications.